NeuOrphan is developing a drug, currently in the preclinical stage of development, that aims to protect the central nervous system from inflammatory damage and promote repair through remyelination - addressing the unmet medical need in patients living with multiple sclerosis progression.
Company Details
- Address
- This Gap Through The Development Of Dioprotectome
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neuorphan.com/
- Keywords
- Pune.
Neuorphan Questions
Neuorphan's website is https://neuorphan.com/
Neuorphan's LinkedIn profile is https://www.linkedin.com/company/neuorphan
Neuorphan's industry is
Biotechnology Research
Neuorphan's categories are Biotechnology Research
